3626 - Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what arrangements he plans to make to ensure that cancer patients have access to essential treatments after the closure of the Cancer Drugs Fund.

George Freeman

Since it was established, the Cancer Drugs Fund has helped over 72,000 people in England to receive the life-extending cancer drugs that would not otherwise have been routinely available to them.

This Government has committed to continuing to invest in the Fund.

3690 - Skin: Diseases (Answered)

Margaret Hodge
To ask the Secretary of State for Health, what steps his Department is taking to ensure that NHS staff are aware of the symptoms and treatment of Stevens-Johnson Syndrome and toxic epidermal necrolysis.

George Freeman

There are between 6,000 and 8,000 recognised rare diseases and an estimated 1 in 17 people will be affected by a rare disease at some point in their lifetime. The Government continues to work hard to raise awareness of, and take action on, rare diseases.

3692 - Skin: Diseases (Answered)

Margaret Hodge
To ask the Secretary of State for Health, how many instances of Stevens-Johnson Syndrome and toxic epidermal necrolysis have been reported in each of the last five years; and in how many of those cases were (a) paracetamol, (b) codeine and (c) other drugs were assessed to be the cause.

George Freeman

3985 - Dementia: Research (Answered)

Mr Gregory Campbell
To ask the Secretary of State for Health, if he will make it his policy to prioritise research on dementia during this Parliament.

George Freeman

As part of the Challenge on Dementia 2020, the National Institute for Health Research, the Medical Research Council, and the Economic and Social Research Council will maintain their current collective spend on dementia research of over £60 million a year. Research spending has already doubled from a baseline of £28.2 million in 2009/10.

4178 - Clinical Priorities Advisory Group: Publications (Answered)

Greg Mulholland
To ask the Secretary of State for Health, who is notified of funding decisions by NHS England's Clinical Priorities Advisory Group before those decisions are published.

George Freeman

NHS England's Clinical Priorities Advisory Group is an advisory committee and does not make decisions.

Funding decisions on new treatments for rare diseases will be made at NHS England's Specialised Commissioning Committee which is taking place on 30 June.

3175 - Haematological Cancer: Drugs (Answered)

Mark Tami
To ask the Secretary of State for Health, if he will make an assessment of the funding and availability of medicines for blood cancer patients in England compared to their counterparts in Scotland and Wales.

George Freeman

3177 - Cancer: Drugs (Answered)

Mark Tami
To ask the Secretary of State for Health, what recent representations he has received on the future of the Cancer Drugs Fund; and if he will make a statement.

George Freeman

Since it was established, the Cancer Drugs Fund has helped over 72,000 people in England to receive the life-extending cancer drugs that would not otherwise have been routinely available to them.

2942 - Health Services (Answered)

Mr George Howarth
To ask the Secretary of State for Health, when he expects the NHS England review of the National Clinical Audit and Patient Outcomes Programme to conclude; and if he will make a statement.

George Freeman

The National Clinical Audit and Patient Outcomes Programme (NCAPOP), managed on behalf of NHS England by the Healthcare Quality Improvement Partnership (HQIP), is a rolling programme of audits.

3083 - Congenital Abnormalities: Research (Answered)

Alison McGovern
To ask the Secretary of State for Health, how much his Department has spent on research into Patau and Edwards Syndrome in each of the last five years.

George Freeman

3176 - Cancer: Drugs (Answered)

Mark Tami
To ask the Secretary of State for Health, if he will make an assessment of the work of the Scottish New Medicines Fund in funding treatments for rarer cancers.

George Freeman

Pages